Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.2M Buy
506,066
+234,964
+87% +$42.6M 0.33% 59
2026
Q1
$39.9M Sell
271,102
-5,000
-2% -$813K 0.24% 70
2025
Q4
$53.8M Sell
276,102
-255,014
-48% -$60.7M 0.35% 59
2025
Q3
$149M Buy
531,116
+191,995
+57% +$48.9M 1.14% 23
2025
Q2
$74.1M Buy
339,121
+176,497
+109% +$28.5M 0.73% 38
2025
Q1
$22.7M Buy
162,624
+162,596
+580,700% +$26.5M 0.24% 58
2024
Q4
$5K Sell
28
-4,472
-99% -$794K ﹤0.01% 143
2024
Q3
$767K Sell
4,500
-3,500
-44% -$507K 0.01% 100
2024
Q2
$1.13M Hold
8,000
0.01% 91
2024
Q1
$1M Buy
8,000
+2,000
+33% +$229K 0.01% 103
2023
Q4
$633K Buy
+6,000
New +$655K 0.01% 102

Other funds holding ORCL

Clal Insurance's ORCL Position: Q2 2026 in Review

Clal Insurance increased its Oracle (ORCL) stake by 87% in Q2 2026, buying an estimated $42.6M and bringing the position to 506,066 shares worth $74.2M. The position accounts for 0.33% of the portfolio, ranked #59.

Clal Insurance first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $149M in Q3 2025. 3,503 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Clal Insurance held 506,066 shares of Oracle worth $74.2M as of Q2 2026.
  • Clal Insurance bought 234,964 Oracle shares in Q2 2026, an estimated $42.6M.
  • Oracle made up 0.33% of Clal Insurance's portfolio in Q2 2026, its #59 holding.
  • Clal Insurance first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Clal Insurance's Oracle position peaked at $149M in Q3 2025.
  • 3,503 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.